Dr. Stephen Hahn, commissioner of the US Food and Drug Administration, said in a Twitter thread on Tuesday that he will be using the social media platform as a way to highlight the work the FDA is doing around a Covid-19 vaccine.
He said that through Twitter and other venues, the agency will continue to “underscore that only science and data will drive FDA’s decisions,” adding that FDA staff will only authorize or approve a vaccine if it meets the high safety and efficacy standards expected by Americans.
While the agency is committed to expediting work around the vaccine, the FDA will not cut corners and have not lost sight of its responsibility to ensure that decisions related to all medical products, including vaccines, are based on science and data, he said.
Hahn tweeted that the FDA has made it clear through guidance what data needs to be submitted to meet regulatory standards, something he called “particularly important” as many people have expressed concerns about vaccine development efforts.
The FDA is also committed to an evaluation process that’s as transparent as possible, with an FDA advisory committee of independent experts meeting in October to publicly discuss vaccine development, Hahn tweeted.
He encouraged Twitter users to follow the hashtag #FDAVaccineFacts as the agency highlights different parts of the development and evaluation process.